See how top analysts and institutions rate PATH — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| BMO Capital Markets | Reiterated | Market Perform | $12.50 → $13 | 2025-10-02 |
| BMO Capital Markets | Reiterated | Market Perform | $15.50 → $12.50 | 2025-09-05 |
| DA Davidson | Resumed | Neutral | $12 | 2025-09-05 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| December 2025 | 0 | 1 | 18 | 0 | 1 |
| November 2025 | 0 | 2 | 17 | 0 | 1 |
| October 2025 | 0 | 2 | 17 | 0 | 1 |
| September 2025 | 0 | 3 | 16 | 0 | 1 |
The majority of institutional investors have issued a "Buy" rating for PATH, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
